about
Do we really know the pharmacodynamics of anaesthetics used in newborns, infants and children? A review of the experimental and clinical data on neurodegeneration.Cytomegalovirus pneumonia as the first manifestation of severe combined immunodeficiency.The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors.Assessment of the Usefulness of Multiplex Real-Time PCR Tests in the Diagnostic and Therapeutic Process of Pneumonia in Hospitalized Children: A Single-Center Experience.Procedural sedation and analgesia for gastrointestinal endoscopy in infants and children: how, with what, and by whom?Procedural sedation and analgesia in children undergoing digestive endoscopic procedures - paediatrician or anaesthesiologist?Endovascular treatment of an adolescent patient with a ruptured intracranial aneurysm - case report and review of literatureAdverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.Flip-Flop Phenomenon in Epidural Sufentanil Pharmacokinetics: A Population Study in Children and Infants.HPLC-MS/MS method for dexmedetomidine quantification with Design of Experiments approach: application to pediatric pharmacokinetic study.Adverse outcomes after percutaneous dilatational tracheostomy versus surgical tracheostomy in intensive care patients: case series and literature reviewExtracorporeal membrane oxygenation (ECMO) as a rescue treatment in acute respiratory distress syndrome caused by AH1N1 virus infection.Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children.Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?Unanticipated difficult airway management in children - the consensus statement of the Paediatric Anaesthesiology and Intensive Care Section and the Airway Management Section of the Polish Society of Anaesthesiology and Intensive Therapy and the PolConsensus statement of the Paediatric Section of the Polish Society of Anaesthesiology and Intensive Therapy on general anaesthesia in children over 3 years of age. Part II.The consensus statement of the Paediatric Section of the Polish Society of Anaesthesiology and Intensive Therapy on general anaesthesia in children over 3 years of age. Part I - general guidelines.Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression.Single ketamine infusion and neurocognitive performance in bipolar depression.Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries.Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression.The consensus statement of the Paediatric Section of the Polish Society of Anaesthesiology and Intensive Therapy on general anaesthesia in children under 3 years of age.Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression.Electroconvulsive therapy and cognitive functions in treatment-resistant depression.Efficacy of plasma exchange in septic shock: a case report.
P50
Q30826590-288BDCFD-8932-4BD7-A16D-1C87D28F3BA8Q35631796-35CF8C1A-45BB-450E-B5CE-F394E7BC7E1AQ36949387-733D5A15-FAF7-4C5A-8BE9-814016BE644BQ37611299-16ECFFBA-D22D-4A4B-8F73-A35F3D411EDDQ38214482-D9B06880-5A62-49B0-BDD0-366A9E3FAD98Q38233869-6A1B759D-56CD-4815-8664-EEE07C818984Q38312579-FCC7F711-2305-4D4D-ACC6-6AF1BF3E853FQ38546483-A9AF908E-9E30-4FE4-993F-54DB1438B1ACQ38782947-1C10857C-2268-4E44-884B-C66DB7EAD1F7Q39010732-BDBA46C5-B3FA-44A1-B5E2-55FCEA974B2FQ41441554-CB197C53-A8C2-4DDD-A7B1-2FF24254D8C8Q42317177-889A2D85-C8B8-41DD-B206-F3679B75A1C8Q43632977-8B032A1B-D862-4925-B243-098AA2188F92Q43852387-245A9F52-0CAC-436C-9822-0F9396D005A0Q47212142-EFED271E-DCE2-4846-BEEB-7DEA8174124DQ47424750-DE247D92-E2F6-441B-9E52-A216197FD9ABQ47424756-D5C5BAE1-AE88-4DCE-9FBA-6AC0A56BEDA3Q47449285-1777CE70-4F3E-4804-9976-B984D4C2560AQ47795826-68480D05-31FE-4365-A968-8CDFE77EA5D2Q47825386-FA128973-C1D9-4F28-A630-1FF87FE097EBQ47951902-626A27CE-C671-4541-9E6D-B09757ADF36FQ47965396-6F37B7CA-0662-40EE-B1F6-B6273845D1ACQ47991540-92577C36-DF3C-4DDC-AE4D-F3999F27BC1FQ48072254-AFD3B76F-704D-4890-B332-E2EE8CC75F24Q51138479-1E3136D5-D06A-4AA6-B358-ECD3A971EE97
P50
description
researcher ORCID ID = 0000-0003-4950-2346
@en
wetenschapper
@nl
name
A Bartkowska-Sniatkowska
@ast
A Bartkowska-Sniatkowska
@en
A Bartkowska-Sniatkowska
@es
A Bartkowska-Sniatkowska
@nl
type
label
A Bartkowska-Sniatkowska
@ast
A Bartkowska-Sniatkowska
@en
A Bartkowska-Sniatkowska
@es
A Bartkowska-Sniatkowska
@nl
prefLabel
A Bartkowska-Sniatkowska
@ast
A Bartkowska-Sniatkowska
@en
A Bartkowska-Sniatkowska
@es
A Bartkowska-Sniatkowska
@nl
P214
P1153
25225055500
P214
P31
P496
0000-0003-4950-2346
P7859
viaf-164110077